ScreenCell® announces its second participation in one of the most important events in the liquid biopsy field in Europe, the General Assembly of the European Liquid Biopsy Society (ELBS). This General Assembly offers a unique opportunity to actively contribute to the democratization of this analytical method.
An event rich in opportunities
This General Assembly of the ELBS will be an opportunity for ScreenCell to engage with key European opinion leaders specializing in liquid biopsy.
These exchanges with some of the most renowned experts in the field will allow us to share our progress, challenge perspectives, and build lasting connections.
Beyond networking, this event also represents a unique opportunity to take part in the strategic decision-making processes that will shape the future of liquid biopsy in Europe.
We will also have the privilege of attending various oral presentations given by both young and experienced researchers. The knowledge gained from these sessions will fuel our own research and development efforts, reaffirming our commitment to staying at the forefront of innovation.
Dr. Georges Uzan will represent ScreenCell® in Madrid
At this event, ScreenCell® will be represented by our Scientific Director, Dr. Georges UZAN. With his extensive expertise in liquid biopsy and circulating tumor cell research, he will embody ScreenCell’s commitment to the European liquid biopsy community.
Would you like to meet Dr. Uzan in Madrid?
Express your interest now by contacting us at: contact@screencell.com
We would be delighted to arrange an on-site meeting to discuss our technologies or explore potential collaborations.
